{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:20:06Z","timestamp":1785795606500,"version":"3.56.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1097\/maj.0b013e31823bbb9b","type":"journal-article","created":{"date-parts":[[2011,12,15]],"date-time":"2011-12-15T11:38:58Z","timestamp":1323949138000},"page":"163-166","source":"Crossref","is-referenced-by-count":11,"title":["Normocalcemic Primary Hyperparathyroidism\u2014Characteristics and Clinical Significance of an Emerging Entity"],"prefix":"10.1016","volume":"343","author":[{"given":"Matthew A.","family":"Shlapack","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali A.","family":"Rizvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred A.","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 2","key":"10.1097\/MAJ.0b013e31823bbb9b_bb0005","first-page":"S97","article-title":"Asymptomatic primary hyperparathyroidism discovered by multichannel biochemical screening: clinical course and considerations bearing on the need for surgical intervention","volume":"Res 6","author":"Parfitt","year":"1991","journal-title":"J Bone Miner"},{"key":"10.1097\/MAJ.0b013e31823bbb9b_bb0010","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jcem-67-6-1294","article-title":"Lack of biochemical progression or continuation of accelerated bone loss in mild asymptomatic primary hyperparathyroidism: evidence for biphasic disease course","volume":"67","author":"Rao","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1097\/MAJ.0b013e31823bbb9b_bb0015","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJM199910213411701","article-title":"A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery","volume":"341","author":"Silverberg","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1097\/MAJ.0b013e31823bbb9b_bb0020","doi-asserted-by":"crossref","first-page":"5348","DOI":"10.1210\/jc.2003-031014","article-title":"\u201cIncipient\u201d primary hyperparathyroidism: a \u201cforme fruste\u201d of an old disease","volume":"88","author":"Silverberg","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1097\/MAJ.0b013e31823bbb9b_bb0025","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1590\/S0004-27302010000200004","article-title":"Normocalcemic primary hyperparathyroidism","volume":"54","author":"Bilezikian","year":"2010","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.1097\/MAJ.0b013e31823bbb9b_bb0030","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1210\/jc.2008-1763","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Third International Workshop","volume":"94","author":"Bilezikian","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1097\/MAJ.0b013e31823bbb9b_bb0035","unstructured":"National Kidney Foundation. Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease Available at: http:\/\/www.kidney.org\/professionals\/kdoqi\/guidelines_bone\/guide1.htm. Accessed May 27, 2011."},{"key":"10.1097\/MAJ.0b013e31823bbb9b_bb0040","first-page":"291","article-title":"Calcareous renal disease and hyperparathyroidism","volume":"34","author":"George","year":"1965","journal-title":"Q J Med"},{"key":"10.1097\/MAJ.0b013e31823bbb9b_bb0045","first-page":"42","article-title":"Normocalcemic primary hyperparathyroidism","volume":"139","author":"Grimelius","year":"1973","journal-title":"Acta Chir Scand"},{"key":"10.1097\/MAJ.0b013e31823bbb9b_bb0050","first-page":"691","article-title":"Normocalcemic hyperparathyroidism, kidney stones, and idiopathic hypercalciuria","volume":"77","author":"Johansson","year":"1975","journal-title":"Surgery"},{"key":"10.1097\/MAJ.0b013e31823bbb9b_bb0055","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1136\/bmj.2.4833.424","article-title":"Hyperparathyroidism with normal serum calcium","volume":"16","author":"Mather","year":"1953","journal-title":"Br Med J"},{"key":"10.1097\/MAJ.0b013e31823bbb9b_bb0060","first-page":"314","article-title":"Normocalcemic hyperparathyroidism","volume":"80","author":"Nichols","year":"1967","journal-title":"Trans Assoc Am Physicians"},{"key":"10.1097\/MAJ.0b013e31823bbb9b_bb0065","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1210\/jcem-35-2-261","article-title":"Gastrointestinal calcium absorption in nephrolithiasis","volume":"35","author":"Pak","year":"1972","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1097\/MAJ.0b013e31823bbb9b_bb0070","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/0002-9343(69)90222-8","article-title":"Normocalcemic primary hyperparathyroidism","volume":"47","author":"Wills","year":"1969","journal-title":"Am J Med"},{"key":"10.1097\/MAJ.0b013e31823bbb9b_bb0075","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1210\/jc.2002-021404","article-title":"Normocalcemic primary hyperparathyroidism: evidence for a generalized target-tissue resistance to parathyroid hormone","volume":"88","author":"Maruani","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1097\/MAJ.0b013e31823bbb9b_bb0080","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.amjmed.2004.06.037","article-title":"Characterization of normocalcemic primary hyperparathyroidism","volume":"117","author":"Tordjman","year":"2004","journal-title":"Am J Med"},{"key":"10.1097\/MAJ.0b013e31823bbb9b_bb0085","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s00268-002-6621-0","article-title":"Primary hyperparathyroidism revisited in menopausal women with serum calcium in the upper normal range at population-based screening 8years ago","volume":"26","author":"Lundgren","year":"2002","journal-title":"World J Surg"},{"key":"10.1097\/MAJ.0b013e31823bbb9b_bb0090","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0039-6060(97)90357-3","article-title":"Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women","volume":"121","author":"Lundgren","year":"1997","journal-title":"Surgery"},{"key":"10.1097\/MAJ.0b013e31823bbb9b_bb0095","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1210\/jc.2006-2802","article-title":"Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype","volume":"92","author":"Lowe","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1097\/MAJ.0b013e31823bbb9b_bb0100","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1590\/S0004-27302006000400010","article-title":"Asymptomatic primary hyperparathyroidism","volume":"50","author":"Bilezikian","year":"2006","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.1097\/MAJ.0b013e31823bbb9b_bb0105","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.surg.2004.06.052","article-title":"Normocalcemic hyperparathyroidism in patients with osteoporosis","volume":"136","author":"Monchik","year":"2004","journal-title":"Surgery"},{"key":"10.1097\/MAJ.0b013e31823bbb9b_bb0110","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1530\/EJE-09-1067","article-title":"Cardiovascular risk factors and arterial rigidity are similar in asymptomatic normocalcemic and hypercalcemic primary hyperparathyroidism","volume":"162","author":"Tordjman","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1097\/MAJ.0b013e31823bbb9b_bb0115","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/BF03346518","article-title":"Endothelial function and endothelial nitric oxide synthase intron 4a\/b polymorphism in primary hyperparathyroidism","volume":"32","author":"Ekmekci","year":"2009","journal-title":"J Endocrinol Invest"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915310491?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915310491?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,23]],"date-time":"2018-07-23T13:24:59Z","timestamp":1532352299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962915310491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0002962915310491"],"URL":"https:\/\/doi.org\/10.1097\/maj.0b013e31823bbb9b","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}